VVM
IMDZ

Versant Venture Management’s Immune Design Corp. IMDZ Stock Holding History

Versant Venture Management’s Portfolio IMDZ Stock Details IMDZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-2,208,210
Closed -$2.87M – 10
2018
Q4 		$2.87M Hold
2,208,210
– – 1.42% 7
2018
Q3 		$7.62M Hold
2,208,210
– – 2.59% 7
2018
Q2 		$10M Hold
2,208,210
– – 3.13% 6
2018
Q1 		$7.29M Hold
2,208,210
– – 2.33% 7
2017
Q4 		$8.61M Hold
2,208,210
– – 9.06% 5
2017
Q3 		$23.2M Hold
2,208,210
– – 17.69% 2
2017
Q2 		$21.3M Hold
2,208,210
– – 16.76% 3
2017
Q1 		$15M Hold
2,208,210
– – 10.92% 5
2016
Q4 		$12.1M Hold
2,208,210
– – 11.82% 5
2016
Q3 		$16.7M Buy
+2,208,210
New +$16.1M 18.66% 2

Other funds holding IMDZ

PS
Peter Svennilson $1.23B AUM 301.34% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.26B AUM 81.38% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GF
Gabelli Funds Rye, New York $15.7B AUM 36.4% 1-Year Est. Return
SAM
Sandell Asset Management New York $179M AUM 65.55% 1-Year Est. Return
BCM
Beryl Capital Management Redondo Beach, California $111M AUM 205.39% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $62.7B AUM 29.77% 1-Year Est. Return

Versant Venture Management's IMDZ Position: Q1 2019 in Review

Versant Venture Management sold out of Immune Design Corp. (IMDZ) in Q1 2019, closing a stake of 2,208,210 shares — an estimated $2.87M sold.

Versant Venture Management first reported a position in IMDZ in Q3 2016 and held it in 10 quarters. The position peaked at $23.2M in Q3 2017. 68 funds tracked by Wall St. Rank hold IMDZ as of Q1 2019.

  • Versant Venture Management reported no remaining Immune Design Corp. position as of Q1 2019 after selling out during the quarter.
  • Versant Venture Management sold 2,208,210 Immune Design Corp. shares in Q1 2019, an estimated $2.87M.
  • Versant Venture Management first reported a position in Immune Design Corp. in Q3 2016 and held it in 10 quarters.
  • Versant Venture Management's Immune Design Corp. position peaked at $23.2M in Q3 2017.
  • 68 funds tracked by Wall St. Rank held Immune Design Corp. as of Q1 2019.

Based on Versant Venture Management's 13F filing for Q1 2019, filed 5 Apr 2019.